The Immune Response Corporation

Organization

Carlsbad, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
HIV immunogenic compositions and methods
- Patent number 6,737,066
- Issue date May 18, 2004
- The Immune Response Corporation
- Ronald B. Moss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vectors and genes exhibiting increased expression
- Patent number 6,642,028
- Issue date Nov 4, 2003
- The Immune Response Corporation
- Charles R. Ill
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-infectious, protease defective HIV particles and nucleic acid m...
- Patent number 6,557,296
- Issue date May 6, 2003
- The Immune Response Corporation
- Ronald B. Luftig
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Membrane-bound cytokine compositions comprising GM-CSF or an active...
- Patent number 6,482,407
- Issue date Nov 19, 2002
- The Immune Response Corporation
- William Soo Hoo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination and methods against multiple sclerosis resulting from p...
- Patent number 6,464,978
- Issue date Oct 15, 2002
- The Immune Response Corporation
- Steven W. Brostoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and methods against psoriasis
- Patent number 6,413,516
- Issue date Jul 2, 2002
- The Immune Response Corporation
- Jennie C. C. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted delivery of genes encoding interferon
- Patent number 6,331,525
- Issue date Dec 18, 2001
- The Immune Response Corporation
- Henry C. Chiou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-infectious, protease defective HIV particles and nucleic acid m...
- Patent number 6,328,976
- Issue date Dec 11, 2001
- Immune Response Corporation
- Ronald B. Luftig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of preventing the proliferation of Vβ14 or Vβ1...
- Patent number 6,221,352
- Issue date Apr 24, 2001
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination and methods against diseases resulting from pathogenic...
- Patent number 6,207,645
- Issue date Mar 27, 2001
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination and methods against diseases resulting from pathogenic...
- Patent number 6,159,470
- Issue date Dec 12, 2000
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and methods against diabetes
- Patent number 6,113,903
- Issue date Sep 5, 2000
- The Immune Response Corporation
- Richard J. Albertini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination and methods against diseases resulting from pathogenic...
- Patent number 6,090,387
- Issue date Jul 18, 2000
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient production and isolation of viral particles utiliz...
- Patent number 6,080,571
- Issue date Jun 27, 2000
- The Immune Response Corporation
- Christopher P. Prior
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted delivery of genes encoding interferon
- Patent number 6,069,133
- Issue date May 30, 2000
- The Immune Response Corporation
- Henry C. Chiou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of retroviral disease
- Patent number 6,017,543
- Issue date Jan 25, 2000
- The Immune Response Corporation
- Jonas Salk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-idiotype vaccination against diseases resulting from pathogeni...
- Patent number 6,007,815
- Issue date Dec 28, 1999
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of preparing polynucleotide-carrier complexes for delivery t...
- Patent number 5,994,316
- Issue date Nov 30, 1999
- The Immune Response Corporation
- Charles P. Lollo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination and methods against diseases resulting from pathogenic...
- Patent number 5,985,552
- Issue date Nov 16, 1999
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of retroviral disease
- Patent number 5,928,930
- Issue date Jul 27, 1999
- Immune Response Corporation
- Jonas Salk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of retroviral disease
- Patent number 5,916,806
- Issue date Jun 29, 1999
- The Immune Response Corporation
- Jonas Salk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of retroviral disease
- Patent number 5,895,650
- Issue date Apr 20, 1999
- The Immune Response Corporation
- Jonas Salk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Membrane-bound cytokine compositions comprising GM=CSF and methods...
- Patent number 5,891,432
- Issue date Apr 6, 1999
- The Immune Response Corporation
- William Soo Hoo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of retroviral disease
- Patent number 5,885,578
- Issue date Mar 23, 1999
- The Immune Response Corporation
- Jonas Salk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination against diseases resulting from pathogenic responses by...
- Patent number 5,861,164
- Issue date Jan 19, 1999
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of retroviral disease
- Patent number 5,853,725
- Issue date Dec 29, 1998
- The Immune Response Corporation
- Jonas Salk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense constructs directed against viral post-transcriptional re...
- Patent number 5,843,770
- Issue date Dec 1, 1998
- The Immune Response Corporation
- Charles R. Ill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccination and methods against diseases resulting from pathogenic...
- Patent number 5,837,246
- Issue date Nov 17, 1998
- The Immune Response Corporation
- Mark D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of viral CIS-acting post-transcriptional regulatory sequences t...
- Patent number 5,744,326
- Issue date Apr 28, 1998
- The Immune Response Corporation
- Charles R. Ill
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of a bacterial component to enhance targeted delivery of polynu...
- Patent number 5,728,399
- Issue date Mar 17, 1998
- University of Conn.
- George Y. Wu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Enhanced activity of HIV vaccine using a second generation immunomo...
- Publication number 20050266015
- Publication date Dec 1, 2005
- Hybridon, Inc.
- Mario Clerici
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Targeted delivery of genes encoding interferon
- Publication number 20040002466
- Publication date Jan 1, 2004
- The Immune Response Corporation
- Henry C. Chiou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Membrane-bound cytokine compositions and methods of modulating an i...
- Publication number 20030108517
- Publication date Jun 12, 2003
- Immune Response Corporation
- William Soo Hoo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
77126976 - PSORIAVAX
- Serial number 77126976
- Filing date Mar 9, 2007
- The Immune Response Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76595390 - NEUROVAX
- Serial number 76595390
- Filing date Jun 4, 2004
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76595391 - RAVAX
- Serial number 76595391
- Filing date Jun 4, 2004
- The Immune Response Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78018708 - RAVAX
- Serial number 78018708
- Filing date Jul 27, 2000
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78018710 - RAVAC
- Serial number 78018710
- Filing date Jul 27, 2000
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78018443 - NEUROVAC
- Serial number 78018443
- Filing date Jul 26, 2000
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78018363 - NEUROVAX
- Serial number 78018363
- Filing date Jul 25, 2000
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78004228 - ZORCELL
- Serial number 78004228
- Filing date Apr 14, 2000
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75483303 - NEUROGENOMICS
- Serial number 75483303
- Filing date May 11, 1998
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75395701 - ZYVAC-RA
- Serial number 75395701
- Filing date Nov 25, 1997
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75179417 - XYVAX
- Serial number 75179417
- Filing date Oct 10, 1996
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75179418 - ZORCELL
- Serial number 75179418
- Filing date Oct 10, 1996
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75031196 - REMUNE
- Serial number 75031196
- Registration number 2464045
- Filing date Dec 11, 1995
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75022688 - GENEDRUG
- Serial number 75022688
- Filing date Nov 21, 1995
- Immune Response Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
74273581 - B PRIME
- Serial number 74273581
- Filing date May 6, 1992
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
74273604 - BETA PRIME
- Serial number 74273604
- Filing date May 6, 1992
- Immune Response Corporation, The
- 5 - Pharmaceutical and veterinary preparations

The Immune Response Corporation

Organization

Patents Grantslast 30 patents

HIV immunogenic compositions and methods

Vectors and genes exhibiting increased expression

Non-infectious, protease defective HIV particles and nucleic acid m...

Membrane-bound cytokine compositions comprising GM-CSF or an active...

Vaccination and methods against multiple sclerosis resulting from p...

Peptides and methods against psoriasis

Targeted delivery of genes encoding interferon

Non-infectious, protease defective HIV particles and nucleic acid m...

Method of preventing the proliferation of V&#x03B2;14 or V&#x03B2;1...

Vaccination and methods against diseases resulting from pathogenic...

Vaccination and methods against diseases resulting from pathogenic...

Peptides and methods against diabetes

Vaccination and methods against diseases resulting from pathogenic...

Highly efficient production and isolation of viral particles utiliz...

Targeted delivery of genes encoding interferon

Prevention and treatment of retroviral disease

Anti-idiotype vaccination against diseases resulting from pathogeni...

Method of preparing polynucleotide-carrier complexes for delivery t...

Vaccination and methods against diseases resulting from pathogenic...

Prevention and treatment of retroviral disease

Prevention and treatment of retroviral disease

Prevention and treatment of retroviral disease

Membrane-bound cytokine compositions comprising GM=CSF and methods...

Prevention and treatment of retroviral disease

Vaccination against diseases resulting from pathogenic responses by...

Prevention and treatment of retroviral disease

Antisense constructs directed against viral post-transcriptional re...

Vaccination and methods against diseases resulting from pathogenic...

Use of viral CIS-acting post-transcriptional regulatory sequences t...

Use of a bacterial component to enhance targeted delivery of polynu...

Patents Applicationslast 30 patents

Enhanced activity of HIV vaccine using a second generation immunomo...

Targeted delivery of genes encoding interferon

Membrane-bound cytokine compositions and methods of modulating an i...

Trademarklast 30 trademarks

77126976 - PSORIAVAX

76595390 - NEUROVAX

76595391 - RAVAX

78018708 - RAVAX

78018710 - RAVAC

78018443 - NEUROVAC

78018363 - NEUROVAX

78004228 - ZORCELL

75483303 - NEUROGENOMICS

75395701 - ZYVAC-RA

75179417 - XYVAX

75179418 - ZORCELL

75031196 - REMUNE

75022688 - GENEDRUG

74273581 - B PRIME

74273604 - BETA PRIME

Method of preventing the proliferation of Vβ14 or Vβ1...